Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial.

Wallace MS, Charapata SG, Fisher R, Byas-Smith M, Staats PS, Mayo M, McGuire D, Ellis D; Ziconotide Nonmalignant Pain Study 96-002 Group..

Neuromodulation. 2006 Apr;9(2):75-86. doi: 10.1111/j.1525-1403.2006.00055.x.

PMID:
22151630
3.

A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.

Rauck RL, Wallace MS, Leong MS, Minehart M, Webster LR, Charapata SG, Abraham JE, Buffington DE, Ellis D, Kartzinel R; Ziconotide 301 Study Group..

J Pain Symptom Manage. 2006 May;31(5):393-406.

PMID:
16716870
4.

Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.

Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, Fisher R, Bryce DA, Mangieri EA, Luther RR, Mayo M, McGuire D, Ellis D.

JAMA. 2004 Jan 7;291(1):63-70.

PMID:
14709577
6.

Continuous Intrathecal Infusion of Ziconotide for Treatment of Chronic Malignant and Nonmalignant Pain Over 12 Months: A Prospective, Open-label Study.

Ellis DJ, Dissanayake S, McGuire D, Charapata SG, Staats PS, Wallace MS, Grove GW, Vercruysse P; Elan Study 95-002 Group..

Neuromodulation. 2008 Jan;11(1):40-9. doi: 10.1111/j.1525-1403.2007.00141.x.

PMID:
22150990
7.

Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.

[No authors listed]

Prescrire Int. 2008 Oct;17(97):179-82.

PMID:
19530373
8.

Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.

Riff DS, Duckor S, Gottlieb I, Diamond E, Soulier S, Raymond G, Boesing SE.

Clin Ther. 2009 Oct;31(10):2072-85. doi: 10.1016/j.clinthera.2009.09.011.

PMID:
19922878
10.

A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain.

Southworth S, Peters J, Rock A, Pavliv L.

Clin Ther. 2009 Sep;31(9):1922-35. doi: 10.1016/j.clinthera.2009.08.026.

PMID:
19843482
13.

An Open-Label, Multicenter Study of the Safety and Efficacy of Intrathecal Ziconotide for Severe Chronic Pain When Delivered via an External Pump.

Ver Donck A, Collins R, Rauck RL, Nitescu P.

Neuromodulation. 2008 Apr;11(2):103-11. doi: 10.1111/j.1525-1403.2008.00150.x.

PMID:
22151042
16.

Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.

Wallace MS, Kosek PS, Staats P, Fisher R, Schultz DM, Leong M.

Pain Med. 2008 Apr;9(3):271-81. doi: 10.1111/j.1526-4637.2007.00355.x.

PMID:
18366507
18.
19.

Efficacy of nonprescription doses of ibuprofen for treating migraine headache. a randomized controlled trial.

Codispoti JR, Prior MJ, Fu M, Harte CM, Nelson EB.

Headache. 2001 Jul-Aug;41(7):665-79.

PMID:
11554954

Supplemental Content

Support Center